Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Attention Disorders"
DOI: 10.1177/1087054714533191
Abstract: Objective: To test whether an optimal dose of Quillivant XR (methylphenidate extended-release oral suspension [MEROS]) would significantly reduce symptoms of ADHD in children. Method: A randomized, double-blind, placebo-controlled, cross-over, efficacy, safety, and tolerability study of…
read more here.
Keywords:
methylphenidate extended;
extended release;
safety;
methylphenidate ... See more keywords